Citizens analyst Daniel Stauder maintains Stereotaxis (AMEX:STXS) with a Market Outperform and lo

TD Cowen analyst Joshua Jennings maintains Stereotaxis (AMEX:STXS) with a Buy and lowers the pric

Stereotaxis, Inc. (STXS) Q2 2026 Earnings Call Transcript

Stereotaxis NYSEAMERICAN: STXS reported second-quarter 2026 revenue of $7.7 million, as growth in sa

Stereotaxis Inc. (STXS) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus

Stereotaxis (AMEX:STXS) reported quarterly losses of $(0.05) per share which beat the analyst consen

ST. LOUIS, Mo., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global lea

ST. LOUIS, July 21, 2026 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NYSE: STXS), a pioneer and global le

First Robotic Magnetic Navigation system installed in Hungary University of Szeged, led by Cardiolog

Callan JMB Inc (CJMB) shares jumped 63.8% in pre-market trading after announcing a strategic partner

Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 28.6% to $0.64 during Thursday's after-

ST. LOUIS and ROUEN, France, July 09, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer a

Stereotaxis NYSEAMERICAN: STXS said its first-quarter results did not yet reflect what management de

Piper Sandler analyst Adam Maeder reiterates Stereotaxis (AMEX:STXS) with a Overweight and lowers

Stereotaxis, Inc. (STXS) Q1 2026 Earnings Call Transcript

Stereotaxis Inc. (STXS) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus

Stereotaxis (AMEX:STXS) reported quarterly losses of $(0.06) per share which missed the analyst cons

Proprietary robotically-navigated MAGiC catheter received U. S. FDA approval in January and is now b

STXS stock gains after first U.S. MAGiC procedures, marking a key milestone in robotic cardiac care

ST. LOUIS, April 22, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader

ST. LOUIS, April 21, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader

Stereotaxis expands in robotic surgery with Robocath acquisition, aiming to build a comprehensive en

Stereotaxis, Inc. (STXS) M&A Call Transcript

Stereotaxis to acquire Robocath, advancing robotic endovascular tech and accelerating expansion into

This acquisition significantly strengthens Stereotaxis' position as a leading platform for the f

ST. LOUIS and ROUEN, France, April 15, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer

STXS jumps on FDA clearance of Synchrony system, a 4K platform integrating cath lab tech with cloud

Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive end

$100,000,000 Debt SecuritiesCommon StockPreferred StockWarrantsRightsUnitsWe may offer and sell from

Stereotaxis (AMEX:STXS) reported quarterly losses of $(0.06) per share which met the analyst consens

Citizens analyst Daniel Stauder initiates coverage on Stereotaxis (AMEX:STXS) with a Market Outpe

Stereotaxis (AMEX:STXS) reported quarterly losses of $(0.07) per share which missed the analyst cons

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K251792

Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive end

Stereotaxis (AMEX: STXS) announces first procedures with Genesis Robotic Magnetic Navigation System

Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive end

Stereotaxis (AMEX:STXS) reported quarterly losses of $(0.05) per share which beat the analyst consen

Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive end